Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of vortioxetine, once daily (QD), on
mood disorders and cognitive dysfunction in patients with head and neck cancers undergoing
radiotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborators:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University Brain Hospital Affiliated to Guangzhou Medical University Sun Yat-sen University